An intervention providing information about inflammatory bowel disease (IBD) can significantly decrease short-term quality of life (QOL)

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.380, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QOL impaired in inflammatory bowel disease

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The QUOTE-IBD is a valid, reliable questionnaire for assessing quality of care in patients with inflammatory bowel disease

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 351, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Can Surgery for Inflammatory Bowel Disease be Personalized?

By  

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 798-804

Bentham Science Publishers

Access to resources Recommend Favorite

Infliximab use appears to increase the risk of heart disorders, including arrhythmias, in children with inflammatory bowel disease (IBD)

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite